Drug recall · May 31, 2017
Infant 25% DEXTROSE Injection recall
Why: Presence of Particulate Matter: human hair found within an internal sample syringe.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1775-10
- Lots / codes
Lot 58382EV*, Exp 1OCT 2017, *lot may be followed by 01 or 02
- Quantity
- 71,550 syringes
- Company
- Hospira Inc., Lake Forest, IL
- Distribution
- Nationwide in the USA and Puerto Rico
- Initiated
- April 21, 2017 · Voluntary: Firm initiated
- Classified
- May 24, 2017
- Reported
- May 31, 2017
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Glucose
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.